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THE INFLUENCE OF EXPERIMENTAL CONDITIONS ON THE RE-
SULTS OF IN VITRO TESTS FOR ANTIFUNGAL ACTION (WITH
SPECIAL REFERENCE TO THE EFFECT OF MAINTAINING SOLU-
BILITY OF THE AGENTS)*
PRELIMINARY REPORT
E. J. FOLEY, F. HERRMANN, M.D. S. W. LEE, PH.D.
The preceding preliminary report (1) pointed out that certain fatty acids
and trimethyl cetyl ammonium pentachiorphenate (TCAP) were more fungicidal
at pH 5 or 6 than at pH 7 or 8. In further experiments still other factors could
be shown to exert powerful influences upon the antifungal action. Thus, the
use of different types of vehicles or media brought about great differences in
results. The following experiment is an example.
One per cent stock preparations of undecylenic acid were made: (a) in water,** (b) in 2%
aqueous triethenolaniine, (c) in propylene glycol and (d) in 95% ethanol. Serial dilutions
were made of these stock preparations: of (a) inwater; of (b) in water with (10 vol. % of)
Mc Ilvanine's buffer at pH 8.5; of (c) in equal parts of water and propylene glycol; and of
(d) in equal parts of water and ethanol. 0.1 ml. of each of these liquids as well as of the
corresponding liquid without the undecylenic acid (blank control) was added to
Sabouraud's maltose agar (Difco) and to broth, (1% neopeptone, 4% glucose). The pH
of these media was adjusted to pH 5 and 7 with Mc Ilvaine's buffer. The final volumes
were 5cc. Broth and slanted agar tubes were inoculated with a heavy suspension of spores
of Trichophyton gypseuin. The minimum concentrations inhibiting growth are shown in
the example on table 1.
TABLE 1
Growth inhibitory concentration of undecylenic acid (mg. per cc.) mixed in various diluents
(see text), in agar or broth adjusted to pH 5 or pH 7
MEDIUM pH WATER
TETEANOLAMINx
WATER BUFFERED
AT pH 8.5
GLYCOL
WATER ALCOHOL WATER
Agar
Broth
5
7
5
7
mg./cc.
0.11
0.20
0.065
0.20
mg./cc.
0.055
0.20
0.016
0.14
mg./cc.
0.02
0.1
0.013
0.08
mg./cc.
0.02
0.1
0.013
0.08
These results again demonstrate that undecylenic acid inhibits more at pH 5
than at pH 7; moreover, higher inhibitory values were obtained when liquids
which increase the solubility were employed, and highest titres were found
when broth was used as the test medium.
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** All aqueous dilutions were shaken until homogeneous for use.
5
6 THE JOURNAL OF INVESTIGATIVE DERMATOLOGY
In a second experiment, preparations (a), (b), (c) and (d) and their blank controls were
compared by a diffusion method, in which inhibitory zones were measured on agar plates
seeded with Trichophyton gypseum: 0.2% concentrations were made in the diluents listed
above; filter paper discs 1 cm. in diameter were dipped in the preparations and placed on
the surface of 10 ml. of inoculated Sabouraud agar in petri dishes. Table 2 shows the
diameters of inhibitory zones, measured after four days.
TABLE 2
Antifun gal activity of 0i?O% undecylenic acid mixed in various diluents (see text) as 8hown
by inhibitory zones (cm.) in agar adjusted to different pH levels
AQAR ADmSTED TO pH WATER
TRIETEANOLAMINE
WATER BUFFERED AT
pH 8.5
PROPYLENE GLYCOL
WATER ALCOHOL WATER
cm. cm. cm. cm.
5 3.2 3.6 4.5 9.0
7 0 1.8 2.2 1.6
8 0 0 0 0
These findings are parallel to those shown in table 1. The effect of pH on
the inhibitory action of undecylenic acid is again apparent. Likewise, the
effect of solubility of the acid is evident. Obviously two factors, an acid medium
and a suitable solvent cooperate in producing maximal efficacy of the agent
under test.
Under experimental conditions which tend to maintain solubility of unde-
cylenic acid (use of propylene glycol, alcohol, aqueous triethanolamine at pH
8.5), higher inhibitory values were obtained (in both, acid and neutral media)
than when aqueous dilutions of the acid were used. The activity under these
conditions is again preponderantly one of the free acid in solution; for the
tables consistently show that the undecylenate-ion (media at pH 7 or 8) is
inferior to the free acid (media at pH 5) in antifungal activity.
Experiments in which similar relationships were observed with other water
insoluble fatty acids (heptylic, caprylic, pelargonic, capric) and TOAP will be
described in a future publication.
The findings described here and in the preceding report are also of interest
in connection with the statements of Rothman and co-workers (2a, b) that
odd-carbon, saturated higher fatty acids present in the sebaceous secretion are
strongly active against microsporon Audouini. It appears probable that the
activity of these acids is greatly enhanced by the sweat secretion, since normal
sweat should bring about both low pH and good dispersion, similar to the
conditions producing optimal activity in our experiments.
SUMMARY
Experiments are described which indicate that the growth inhibitory activity
of undecylenic acid against pathogenic fungi in vitro is dependent upon pH and
solubility. Thus the types of vehicles and of media chosen can be of decisive
influence on the results of studies of antifungal action.
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